Cargando…
Efficacy of more intensive lipid-lowering therapy on cardiovascular diseases: a systematic review and meta-analysis
BACKGROUND: Cardiovascular disease is the leading cause of morbidity and mortality with incidence rates of 5–10 per 1000 person-years, according to primary prevention studies. To control hyperlipidemia—a major risk factor of cardiovascular disease—initiation of lipid-lowering therapy with therapeuti...
Autores principales: | Hsu, Hsin-Yin, Lin, Chien-Ju, Lee, Yu-Shan, Wu, Ting-Hui, Chien, Kuo-Liong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359015/ https://www.ncbi.nlm.nih.gov/pubmed/32660417 http://dx.doi.org/10.1186/s12872-020-01567-1 |
Ejemplares similares
-
Association of baseline as well as change in lipid levels with the risk of cardiovascular diseases and all-cause deaths
por: Hsu, Hsin-Yin, et al.
Publicado: (2021) -
Efficacy and Safety of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors as Adjuvant Treatments for Patients with Hypercholesterolemia Treated with Statin: A Systematic Review and Network Meta-analysis
por: Huang, Yi-Ting, et al.
Publicado: (2022) -
Lipid biomarkers and Cancer risk - a population-based prospective cohort study in Taiwan
por: Chang, Yu-Chen, et al.
Publicado: (2021) -
The Relationship between Metabolically Healthy Obesity and the Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis
por: Yeh, Tzu-Lin, et al.
Publicado: (2019) -
Combined healthy lifestyle factors are more beneficial in reducing cardiovascular disease in younger adults: a meta-analysis of prospective cohort studies
por: Tsai, Ming-Chieh, et al.
Publicado: (2020)